News

The company submitted a new drug application to the FDA seeking approval for the intravenous administration of the drug in adjunctive therapy for the treatment of partial onset

The drug is the only treatment currently available in the US for the prevention of the disease. There has been a gap in the market for such a

The product tests for H5 influenza of which bird flu (H5N1) is a subtype. The test returns results on a sample within four hours, compared with the two

The study in 48 young healthy subjects, of whom 36 received EVT 101, showed that the drug was well absorbed, extremely well tolerated with no significant adverse events,

The company will evaluate Combretastatin A4P (CA4P), in combination with concurrent chemo-radiotherapy, a widely accepted standard in the US for the treatment of unresectable stage IIIa/IIIb non small

The trial, known as MIRA-1, did not demonstrate a statistically significant difference in the mean change of best spectacle-corrected visual acuity between the treated and placebo groups at

If approved, SPD476 would offer a once-daily mesalazine treatment for the disorder. Last year, the mesalazine market segment for ulcerative colitis was worth around $1.6 billion. “The European

Neuroblastoma is the most common extracranial solid tumor in children younger than five years of age. Despite advances in modern therapy, metastatic neuroblastoma remains incurable. One barrier to

The open-label study enrolled eight patients with normal testosterone levels, four with borderline testosterone levels, and one with low testosterone. Study subjects received 25mg of Androxal orally for